R & B Pharma Ltd. in London, W5 3RA

Description

Data updated on: 01-11-2023

The date the firm was founded is 2009-07-06. Established under 06953572, the company is registered as a Private Limited Company. You can contact the headquarters of the firm during office hours at the following location: 7-8 Ritz Parade Western Avenue, W5 3RA London. The enterprise's SIC code is 47730: Dispensing chemist in specialised stores. The company's most recent filed accounts documents were submitted for the period up to Wed, 30th Nov 2022 and the most current annual confirmation statement was filed on Mon, 3rd Jul 2023.

This company has a solitary director presently running this company, namely Rashmi P. who's been doing the director's duties since 2009-07-06. In addition, the director's assignments are often backed by a secretary - Bhavi P., who was appointed by the following company in July 2009.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2013-11-30	2014-11-30	2015-11-30	2016-11-30	2017-11-30	2018-11-30	2019-11-30
Currency
Net Worth	407 096	555 356	724 796	914 544

Balance Sheet
Cash Bank On Hand				477 225	701 081	961 822	1 195 212
Current Assets	375 841	430 474	577 421	712 418	940 213	1 116 279	1 341 355
Debtors	98 141	178 399	187 477	198 039	203 420	114 344	109 931
Net Assets Liabilities				914 543	1 107 103	1 294 186	1 489 515
Property Plant Equipment				68 493	58 702	50 504	44 457
Total Inventories				37 154	35 712	40 113	36 212
Cash Bank In Hand	252 579	217 622	353 732	477 225
Intangible Fixed Assets	462 010	434 833	407 656	380 479
Net Assets Liabilities Including Pension Asset Liability	407 096	555 356	724 796	914 544
Stocks Inventory	25 121	34 453	36 212	37 154
Tangible Fixed Assets	20 236	17 586	17 134	68 493

Capital & Reserves
Called Up Share Capital	100	100	100	100
Profit Loss Account Reserve	406 996	555 256	724 696	914 444
Shareholder Funds	407 096	555 356	724 796	914 544

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets				163 062	190 239	217 416	244 593
Accumulated Depreciation Impairment Property Plant Equipment				29 406	39 767	48 677	56 521
Average Number Employees During Period						7	7
Creditors				189 435	218 917	188 938	187 213
Fixed Assets	483 012	453 363	427 732	451 914	414 946	379 571	346 347
Increase From Amortisation Charge For Year Intangible Assets					27 177	27 177	27 177
Increase From Depreciation Charge For Year Property Plant Equipment					10 359	8 912	7 844
Intangible Assets				380 479	353 302	326 125	298 948
Intangible Assets Gross Cost				543 541	543 541	543 541	543 541
Investments Fixed Assets	766	944	2 942	2 942	2 942	2 942	2 942
Net Current Assets Liabilities	103 477	233 434	386 975	522 984	721 296	927 341	1 154 142
Property Plant Equipment Gross Cost				97 899	98 467	99 183	100 978
Total Additions Including From Business Combinations Property Plant Equipment					568	714	1 797
Total Assets Less Current Liabilities	586 489	686 797	814 707	974 898	1 136 242	1 306 912	1 500 489
Creditors Due After One Year	179 393	131 441	89 911	60 354
Creditors Due Within One Year	272 364	197 040	190 446	189 434
Intangible Fixed Assets Aggregate Amortisation Impairment	81 531	108 708	135 885	163 062
Intangible Fixed Assets Amortisation Charged In Period		27 177		27 177
Intangible Fixed Assets Cost Or Valuation	543 541	543 541	543 541	543 541
Number Shares Allotted		100		100
Par Value Share		1		1
Share Capital Allotted Called Up Paid	100	100	100	100
Tangible Fixed Assets Additions		453		63 447
Tangible Fixed Assets Cost Or Valuation	31 427	31 880	34 452	97 899
Tangible Fixed Assets Depreciation	11 191	14 294	17 318	29 406
Tangible Fixed Assets Depreciation Charged In Period		3 103		12 088

Company staff

Bhavi P.

Role: Secretary

Appointed: 06 July 2009

Latest update: 17 April 2024

Rashmi P.

Role: Director

Appointed: 06 July 2009

Latest update: 17 April 2024

People with significant control

Executives with significant control over the firm are: Rashmi P. has substantial control or influence over the company owns 1/2 or less of company shares and has 1/2 or less of voting rights. Bhavi P. has substantial control or influence over the company owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Rashmi P.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

substantial control or influence

1/2 or less of shares

Bhavi P.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

substantial control or influence

1/2 or less of shares

Accounts Documents

Account next due date	31 August 2024
Account last made up date	30 November 2022
Confirmation statement next due date	17 July 2024
Confirmation statement last made up date	03 July 2023

Annual Accounts 25 June 2015
Start Date For Period Covered By Report	2013-12-01
End Date For Period Covered By Report	2014-11-30
Date Approval Accounts	25 June 2015
Annual Accounts 1 August 2017
Start Date For Period Covered By Report	2015-12-01
End Date For Period Covered By Report	2016-11-30
Date Approval Accounts	1 August 2017
Annual Accounts
Start Date For Period Covered By Report	2016-12-01
End Date For Period Covered By Report	2017-11-30
Annual Accounts
Start Date For Period Covered By Report	2017-12-01
End Date For Period Covered By Report	2018-11-30
Annual Accounts
Start Date For Period Covered By Report	2018-12-01
End Date For Period Covered By Report	2019-11-30

R & B Pharma Ltd.

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Bhavi P.

Rashmi P.

People with significant control

Rashmi P.

Bhavi P.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies